Study on education program for patients on biotherapy
Part of Immune system & allergy clinical trials.
This trial tests whether a therapeutic education program helps people with chronic inflammatory diseases who are on biotherapy injections stick to their treatment and feel better. The program aims to improve compliance and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and have a chronic inflammatory disease (like rheumatoid arthritis, psoriasis, or Crohn's disease) that is being treated with a biotherapy injection you give yourself.
- You must start the education program within 3 months of joining the study.
- You must not have any condition that makes it hard to understand or participate in the program, such as serious memory or thinking problems.
- You cannot be pregnant.
- You must be covered by health insurance (like Social Security in France).
- You must be able and willing to give your consent to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a study that follows people with an immune-related illness at Lille University Hospital to better understand their care needs over time. By collecting information regularly, the study may help improve how future patients are monitored and treated.
This trial tests a structured IBD (inflammatory bowel disease) management program that includes incentives to help people follow care plans. It aims to improve patients’ quality of life by supporting ongoing education and follow-up.
This study tests whether a special education program can help improve how you see yourself while living with chronic inflammatory arthritis. If you already take part in your clinic's education sessions, you can join to see if an extra focus on self-image makes a difference.
This study looks at how chronic inflammatory illnesses progress over time and how treatments affect symptoms and disease markers. You may be invited if you’re receiving care for certain bowel, joint, or skin inflammatory conditions at the hospital.
This study follows patients with inflammatory or autoimmune diseases that are not well controlled by standard treatments. Researchers want to learn how safe and effective new immune-modulating medications are when they are tried next.
This trial tests a therapeutic education program for adults with obesity, type 2 diabetes, or other metabolic issues. It aims to help you better manage your health through online learning and support.
Hear when a new Chronic Inflammatory Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.